Suven Life Sciences Competitors and Similar CompaniesClear all
Suven Life Sciences's competitors and similar companies include ACADIA Pharmaceuticals, Supernus Pharmaceuticals, Alector and Neurim Pharmaceuticals.
 Suven Life Sciences Suven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS. |  ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. |  Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. |  Neurim Pharmaceuticals Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders. | |
Founding Date | Founding Date 1989 | Founding Date 1993 | Founding Date 2005 | Founding Date 2013 | Founding Date 1991 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Hyderabad, IN HQ Dasaigudem, IN Hyderabad, IN Sangareddy, IN South Brunswick Township, US | Locations San Diego, US HQ Princeton, US | Locations Rockville, US HQ | Locations San Francisco, US HQ | Locations Tel Aviv-Yafo, IL HQ Zug, CH |
Employees | Employees 141 | Employees 513 | Employees 6527% increase | Employees 2382% decrease | Employees 20 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.4 b | Valuation ($) 1.9 b | Valuation ($) 495.3 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ₹71.1m (FY, 2026) | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) $719m (FY, 2025) | Revenue (est.) $21m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $89m (FY, 2025) | Cost of goods $74.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ₹210.4m (FY, 2026) | Gross profit $982.5m (FY, 2025) | Gross profit $644.4m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income (₹2.8b) (FY, 2026) | Net income $391m (FY, 2025) | Net income ($38.6m) (FY, 2025) | Net income ($142.9m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 32m | Total funding raised $ 770.8m | Total funding raised $ 69.5m | Total funding raised $ 194.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
513
ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View companySupernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View companyAlector
HQ
San Francisco, US
Employees
238↓ 2% decrease
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View companyNeurim Pharmaceuticals
HQ
Tel Aviv-Yafo, IL
Employees
20
Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders.
View company